Stocks and Investing Stocks and Investing
Mon, March 18, 2024

Raghuram Selvaraju Maintained (AQST) at Strong Buy with Increased Target to $9 on, Mar 18th, 2024


Published on 2024-10-28 09:45:17 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Maintained "Aquestive Therapeutics, Inc." (AQST) at Strong Buy with Increased Target from $7 to $9 on, Mar 18th, 2024.

Raghuram has made no other calls on AQST in the last 4 months.



There are 3 other peers that have a rating on AQST. Out of the 3 peers that are also analyzing AQST, 0 agree with Raghuram's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Raghuram


  • Jason Butler of "JMP Securities" Maintained at Buy with Increased Target to $10 on, Friday, March 15th, 2024
  • Thomas Flaten of "Lake Street" Maintained at Strong Buy with Increased Target to $8 on, Thursday, March 7th, 2024
  • Andreas Argyrides of "Wedbush" Maintained at Buy with Increased Target to $9 on, Thursday, March 7th, 2024
Contributing Sources